Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acrocyanosis
advances in neurology
adverse drug reaction
agitation
Aicardi-Goutieres syndrome
airway obstruction
akathisia
alternating hemiplegia
alternating hemiplegia of childhood
Alzheimer's disease
AMPA receptor antibodies
anticholinergic drugs
anticholinesterase
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
antiemetic
antihistamines
atypical
autoantibodies
autoimmune basal ganglia encephalitis
autoimmune encephalopathy
autonomic dysfunction
bacterial infection
ballismus, bilateral
basal ganglia, calcification of
basal ganglia, lesion of
basal ganglia, lesion, bilateral
basilar artery migraine
behavioral disorder, acute
blepharospasm
botulinum toxin
botulinum toxin, complications of
brain atrophy
brain damage
Brueghel's syndrome
butyrophenone
calcification, intracranial
calcium antagonist
calcium antagonist, side effects of
carcinoma
CAT scan
CAT scan, abnormal
catatonia
caudate nucleus, lesion of
cerebral cortex
cerebral cortical atrophy
cerebral palsy
cerebral palsy, adults
cerebral palsy, associated problems with
cerebrospinal fluid, abnormal
cerebrovascular accident
cetirizine
chilbran skin lesions
children
chlorpromazine
chorea
choreoathetosis
cinnarizine
cocaine
collapsin response mediator protein 5 IgG
complications
confusion
creatine phosphokinase(CPK)elevated
cultured skin fibroblasts
deep gray nuclei
dementia
dementia, rapidly progressive
dementia, reversible
dentate nuclei, lesion of
depression
diagnostic criteria
diarrhea
differential diagnosis
diphenhydramine
disability, neurological
donepezil
dopamine antagonist
DPPX, antibodies, encephalitis
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, facial
dysphagia
dystonia
dystonia, cervical
dystonia, children
dystonia, drug induced
dystonia, face
dystonia, focal
dystonia, symptomatic
dystonia, treatment of
dystonia, truncal
dystonic reaction, acute
efficacy
electroencephalogram
electroencephalogram, abnormalities of
emergencies, neurologic
encephalitis
encephalitis, autoimmune
encephalitis, etiology
encephalitis, viral
encephalopathy
enzyme, defect
epidemiology of neurology
faciobrachial dystonic seizure
familial
feeding disorder
felbamate
fever
flunarizine
gamma amino butyric acid receptor antibody
gender
gene
gene mutation
genetic diagnosis, prenatal
genetic neurologic disorders
glutaric acidemia
glutaric aciduria
haloperidol
head lag
headache
hemiballismus
hemichorea
hemifacial spasm
hemiplegia
herpes simplex encephalitis
hyperekplexia
hyperpyrexia, CNS disorder causing
hyperthermia
hyponatremia
hypotonia
iatrogenic neurologic disorders
immunotherapy
inborn errors of metabolism
infantile hemiplegia
insomnia
intellectual deficit
interferon alpha
intrauterine
irritability
leucine rich glioma inactivated 1 antibodies
leukodystrophy
leukoencephalopathy
level of consciousness, decreased
limbic encephalitis
memory, defect of recent
memory, impairment of
mental retardation
mental status, abnormal
mesial temporal lobe
metoclopramide
microcephaly
migraine
migraine, hemiplegic
misdiagnosis
monoclonal antibodies
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, extrapyramidal-treatment of
movement disorder, treatment of
MRI
MRI, abnormal
MRI, false negative
MRI, FLAIR
MRI, negative
MRI, serial
myelitis, transverse, recurrent
myelopathy
myoclonus
neck weakness
neurexin-3 alpha antibodies
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic complications
neurologic disease, diagnoses of
neurologic signs
neuronal cell surface antigen
neuropathology
NMDA antagonists
nystagmus
Parkinson disease
Parkinson disease, drug induced
Parkinsonism syndrome
personality change
phenothiazine
phenothiazine, dyskinesia associated with
Pisa syndrome
pleocytosis of cerebrospinal fluid
postural abnormality
potassium channel antibodies
precipitating factors
prenatal
prevention of neurologic disorders
prognosis
psychiatric disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
putamen, lesion of
pyramidal tract dysfunction
recurrent
renal failure
restless leg syndrome
review article
rhabdomyolysis
rigidity
risk factors
rituximab
safety
schizophrenia
seizure
seizure, dystonic
seizure, psychomotor-temporal lobe
serologic testing
serologic testing, false negative
skin, lesions in neurologic disorders
spastic dysphonia
speech disorder, childhood
startle reaction
status dystonicus
striatal encephalitis
striatum, lesion of
striatum, lesion of, bilateral
symmetric brain lesions
tardive dyskinesia
tardive dystonia
tasikinesia
temporal lobe, lesion
temporal lobe, lesion, bilateral
teratoma
teratoma, ovarian
tetrabenazine
thymoma
tic
torticollis
transient neurologic deficit
treatment of neurologic disorder
tremor
tricyclic antidepressant
weakness
weakness, generalized
weight loss
white matter disease
white matter disease, subcortical
Showing articles 650 to 700 of 9816 << Previous Next >>

Oxcarbazepine: Double-blind, Randomized, Placebo-control, Monotherapy Trial for Partial Seizures
Neurol 52:732-737, Schachter,S.C. et al, 1999

Bilateral Posterior Ischemic Optic Neuropathy After Spinal Surery
Am J Ophthal 127:354-355, Alexandrakis,G.&Lam,B.L., 1999

Psychiatric Adverse Events During Vigabatrin Therapy
Neurol 53:1503-1511, Levinson,D.F.&Devinsky,O., 1999

Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999

Diagnosing Dementia with Lewy Bodies
Lancet 354:1227-1228, McKeith,I.G.,et al, 1999

Multisystem Hypersensitivity Reaction to Lamotrigine
Neurol 53:1367, Sarris,B.M.&Wong,J.G., 1999

Polymerase Chain Reaction in the Diagnosis and Management of Central Nervous System Infections
Arch Neurol 56:1215-1219, DeBiasi,R.L.&Tyler,K.L., 1999

Exotic Diseases Close to Home
Lancet 354:1221,1261, Briese,T.,et al, 1999

Evaluation of Refractory epilepsy Treated with Vagus Nerve Stimulation for Up to 5 Years
Neurol 52:1265-1267,1117, Ben-Menachem,E.,et al, 1999

Transderm-induced Psychosis in Parkinson's Disease
Neurol 53:433-434, Minagar,A.,et al, 1999

Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999

Clinicopath Conf,Multifocal Inflammatory Leukoencephalopathy Related to Combination Chemo with Fluorouracil/levamisole
NEJM 341:512-519, Case 24-1999, 1999

Diagnosis of Viral Infections of the Central Nervous System
NEJM 340:483-484, Huang,C.,et al, 1999

Central Anticholinergic Syndrome on Therapeutic Doses of Cyproheptadine
Pediatrics 103:158-160, Watemberg,N.M.,et al, 1999

Acute Cerebellitis Caused by Coxiella Burnetii
Ann Neurol 45:124-127, Sawaishi,Y.,et al, 1999

The Association of the Combination of Sumatriptan and Methysergide in Myocardial Infarction in a Premenopausal Woman
Arch Int Med 159:511-513, Liston,H.,et al, 1999

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999

Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999

Reye's Syndrome in the United States from 1981 Through 1997
NEJM 340:1377-1382,1423, Belay,E.D.,et al, 1999

Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society
Neurol 52:1540-1545, French,J.,et al, 1999

Intractable Epilepsy
Lancet 353:1238, Shuper,A.,et al, 1999

High Incidence of Secondary Brain Tumours after Radiotherapy and Antimetabolites
Lancet 354:34-39, Relling,M.V.,et al, 1999

Generalised Muscular Weakness after Botulinum Toxin Injections for Dystonia:A Report of Three Cases
JNNP 67:90-93, Bhatia,K.P.,et al, 1999

Leukoencephalopathy and Raised Brain Lactate from Heroin Vapor Inhalation ("Chasing the Dragon")
Neurol 53:589-1048, Kriegstein,A.R., et al, 1999

Thrombolysis-Related Intracranial Hemorrhage, Analysis of 224 Cases from GUSTO-1 Trial with Clin Correl
Stroke 29:563-569, Gebel,J.M.,et al, 1998

PROACT:Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute MCA Stroke
Stroke 29:4-11, delZoppo,G.J.,et al, 1998

I. V. t-PA for Acute Ischemic Stroke, Feasibility, Safety & Efficacy in the First Year of Clinical Practice
Stroke 29:18-22, Chiu,D.,et al, 1998

Rhabdomyolysis and Hypoxia Associated with Prolonged Propofol Infusion in Children
Neurol 50:301-303, Hanna,J.P.&Ramundo,M.L., 1998

Diagnosis of Cytomegalovirus Encephalitis in Pts with AIDS by Cytomegalovirus Genomes in Cells of Cerebrospinal Fluid
Neurol 50:693-697, Wildemann,B.,et al, 1998

An Algorithm (Decision Tree) for the Management of Parkinson's Disease:Trtm Guidelines
Neurol 50:S1-S57, Olanow,C.W.&Koller,W.C., 1998

Secondary Hyperkalaemic Paralysis
JNNP 64:249-252, Evers,S.,et al, 1998

Slater Revisited:6 Year Follow Up Study of Pts with Medically Unexplained Motor Symptoms
BMJ 316:582-586, 5641998., Crimlisk,H.L.,et al, 1998

Lhermitte's Sign Following Chemotherapy with Docetaxel
Neurol 50:563-564, van den Bent,M.J.,et al, 1998

Low Molecular Wt Heparinoid
ORG 10172 (Danaparoid) , & Outcome After Acute Ischemic Stroke, 10172 Acute Stroke Trtm (TOAST) Inve, t, JAMA 1272,1304,1998., 1998

Prevent of a 1st Stroke by Transfusions in Children/Sickle Cell Anemia & Abnorm Results on Transcr Doppler Ultrasonog
NEJM 339:5-11, Adams,R.J.,et al, 1998

Illicit Drug-Associated Ischemic Stroke in the Baltimore-Washington Young Stroke Study
Neurol 50:1688-1693, Sloan,M.A.,et al, 1998

Influence of Human Immunodeficiency Virus 1 Infection and Degree of Immunosuppression in the Clinical Characteristics and Outcome of Infective Endocarditis in Intravenous Drug Users
Arch Int Med 158:2043-2050, Ribera,E.,et al, 1998

Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies
NEJM 339:1994-2004, Johnson,R.T. & Gibbs,Jr.,C.J., 1998

Use of the Polymerase Chain Reaction in the Diagnosis of Herpes Simplex Encephalitis:A Decision Analysis Model
Am J Med 105:287-295, Tebas,P.,et al, 1998

A 6-Year-Old Child with Vacant Episodes and Unilateral Convulsions
Lancet 352:1750, Burgner,D.,et al, 1998

Dystonia and Chorea in Acquired Systemic Disorders
JNNP 65:436-445, Janavs,J.L.&Aminoff,M.J., 1998

Intracerebral Haemorrhage Caused by Drug Abuse
Lancet 351:1029, McEvoy,A.W.,et al, 1998

Tardive Dyskinesia:Diagnosis, Pathogenesis, and Management
The Neurologist 4:180-187, Trugman,J.M., 1998

Acute Transverse Myelitis Associated with Tuberculin Skin Test (PPD)
Neurol 50:1921-1922, Jing,W.,et al, 1998

Early Neurologic Complications Following Allogeneic Bone Marrow Transplant for Leukemia, a Prospective Study
Neurol 50:1441-1445, Antonini,G.,et al, 1998

Atypical Herpes Simplex Virus Encephalitis Diagnosed by PCR Amplification of Viral DNA from CSF
Neurol 51:554-559, Fodork,P.A.,et al, 1998



Showing articles 650 to 700 of 9816 << Previous Next >>